Filters

Soundarya Ramesh, Shannon D Almeida, Sameerana Hammigi, Govardan Katta Radhakrishna, Golla Sireesha, Theivendren Panneerselvam, Shangavi Vellingiri, Selvaraj Kunjiappan, Damodar Nayak Ammunje, Parasuraman Pavadai

Drug research 2023;73(9):491-505

Free Full Text

Abstract

Alternative mechanisms of inhibiting activity of poly (ADP-ribose) polymerase-1.

Chandra Shaker Sriram, Ashok Jangra, Babul Kumar Bezbaruah, Athira K V, Shivaji Sykam

Frontiers in bioscience (Scholar edition) 2016;8(1):123-8

Free Full Text

Abstract

Poly(adenosine 5'-diphosphate) ribose polymerase activation as a cause of metabolic dysfunction in critical illness.

Lucas Liaudet

Current opinion in clinical nutrition and metabolic care 2002;5(2):175-84

Full Text

Abstract

Poly(ADP-ribose) polymerase in DNA damage-response pathway: implications for radiation oncology.

V A Soldatenkov, M Smulson

International journal of cancer 2000;90(2):59-67

Full Text

Abstract

The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism.

Magdolna Szántó, Peter Bai

Genes & development 2020;34(5-6):321-340

Free Full Text

Abstract

Results: 1 – 15 / 118

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Poly(ADP-ribose) Polymerases""[mesh_terms]

Role of Nuclear NAD in Retinal Homeostasis.

A new facet of ADP-ribosylation reactions: SIRTs and PARPs interplay.

Autophagy is a survival force via suppression of necrotic cell death.

Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors.

NAD metabolism in peripheral neuropathic pain.

From toxins to mammalian enzymes: the diversity of mono-ADP-ribosylation.

Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer.

Superoxide, NO, peroxynitrite and PARP in circulatory shock and inflammation.

PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools.

NAD-A Hub of Energy Metabolism in Heart Failure.

A Review of PARP-1 Inhibitors: Assessing Emerging Prospects and Tailoring Therapeutic Strategies.

Alternative mechanisms of inhibiting activity of poly (ADP-ribose) polymerase-1.

Poly(adenosine 5'-diphosphate) ribose polymerase activation as a cause of metabolic dysfunction in critical illness.

Poly(ADP-ribose) polymerase in DNA damage-response pathway: implications for radiation oncology.

The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism.

Results for
""Poly(ADP-ribose) Polymerases""[mesh_terms]